Stay updated with breaking news from Ingram Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Higher T-cell inflamed GEP values were positively associated with clinical outcomes for pembrolizumab plus axitinib in advanced clear cell RCC.
Brian I. Rini, MD, FASCO, discusses the research that led to the FDA approval of belzutifan for patients with advanced renal cell carcinoma.
Drs Kitko and Patel discuss graft-versus-host disease recognition, treatment selection, and ongoing research with novel agents and biomarkers of response.
Vanderbilt University Medical Center has been awarded a $5 million grant from the Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Out
Vanderbilt University Medical Center has been awarded a $5 million grant from the Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Out